Alterix
Beverly, US · Founded 2012 · Delaware corporation
Founders & leadership
PT
Patrick T. Mooney, M.D.Executive
DR
David R. Staskin, M.D.Executive
Board
JD
Janice D. DiPietro, D.B.A.Board director
GG
Galen Grayson, M.D.Board director
HG
Harry G. McCoy, Pharm.D.Board director
JJ
John J. Clark Jr.Board director
FA
Frank A. MangusoBoard director
FD
Frederic de BureBoard director
Reported raises · per SEC filings
Form D private placements$4.3M disclosed across 1 round · 2015
▶$4.3MraisedSep 2015 · 2 investors · PharmaceuticalsRule 506(b)
▶$4.3MraisedSep 2015 · 2 investors · Pharmaceuticals
Rule 506(b)Officers, directors & promoters on the filing
- Janice D. DiPietro, D.B.A.Director
- Galen Grayson, M.D.Director
- Harry G. McCoy, Pharm.D.Director
- John J. Clark Jr.Director
- Frank A. MangusoDirector
- Patrick T. Mooney, M.D.Executive Officer, Director
- David R. Staskin, M.D.Executive Officer, Director
- Frederic de BureDirector
- Amount sold
- $4.3M
- Sales commissions
- $600K
- Proceeds to insiders
- $550K
- Placement agents
- Alexander Capital, LP
- First sale
- Aug 2015
- Incorporated
- Corporation, Delaware, 2012
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Frequently asked questions
- How much funding has Alterix raised?
- Alterix has disclosed $4.3M raised across 1 round.
- Where is Alterix headquartered?
- Alterix is headquartered in Beverly, US.